Ticker	Volume	Price	Price Delta
DJIA	15,224.50	-70.04	-0.46%
S&P 500	1,639.27	-11.24	-0.68%
Nasdaq	3,438.93	-20.49	-0.59%

Ticker

Volume

Price

Price Delta

DJIA

15,224.50

-70.04

-0.46%

S&P 500

1,639.27

-11.24

-0.68%

Nasdaq

3,438.93

-20.49

-0.59%

Ticker	Volume	Price	Price Delta
STOXX 50	2,757.84	-18.94	-0.68%
FTSE 100	6,656.75	-40.04	-0.60%
DAX	8,293.14	-58.84	-0.70%

Ticker

Volume

Price

Price Delta

STOXX 50

2,757.84

-18.94

-0.68%

FTSE 100

6,656.75

-40.04

-0.60%

DAX

8,293.14

-58.84

-0.70%

Ticker	Volume	Price	Price Delta
Nikkei	14,612.50	+128.47	0.89%
Hang Seng	22,618.70	-51.01	-0.23%
S&P/ASX 200	4,983.50	-78.95	-1.56%

Ticker

Volume

Price

Price Delta

Nikkei

14,612.50

+128.47

0.89%

Hang Seng

22,618.70

-51.01

-0.23%

S&P/ASX 200

4,983.50

-78.95

-1.56%

Sekisui to Buy Genzyme’s Test-Drug Operations For $265 Million

By Go Onomitsu - 2010-11-18T05:06:42Z

Sekisui Chemical Co. agreed to buy Genzyme Corp.’s test-drug operations for $265 million, according to a statement to the Tokyo Stock Exchange today.

To contact the reporter on this story: Go Onomitsu in Tokyo at gonomitsu@bloomberg.net

To contact the editor responsible for this story: Kyung Bok Cho at kcho7@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.